Singapore's GIC invests $1b in pharma company Grifols's US unit

Singapore's GIC invests $1b in pharma company Grifols's US unit

REUTERS/Anshuman Daga

Singapore’s wealth fund GIC agreed to invest around 1 billion dollars in Biomat, a U.S.-based plasma collection company owned by Grifols, thus becoming a strategic investor in the Spanish pharmaceutical company, Grifols said on Wednesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter